Mohamed Ehab Ali

ORCID: 0000-0003-2755-9616
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Advanced Drug Delivery Systems
  • Advancements in Transdermal Drug Delivery
  • Inhalation and Respiratory Drug Delivery
  • Aerosol Filtration and Electrostatic Precipitation
  • Veterinary Medicine and Surgery
  • Nanoparticle-Based Drug Delivery
  • Transgenic Plants and Applications
  • Inflammatory Bowel Disease
  • Microencapsulation and Drying Processes
  • Rheumatoid Arthritis Research and Therapies
  • Congenital Anomalies and Fetal Surgery
  • Monoclonal and Polyclonal Antibodies Research
  • Proteins in Food Systems
  • Veterinary Oncology Research
  • Urological Disorders and Treatments
  • Multiple Sclerosis Research Studies
  • Collagen: Extraction and Characterization
  • Drug Solubulity and Delivery Systems
  • Peripheral Neuropathies and Disorders
  • Microscopic Colitis
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Acute Lymphoblastic Leukemia research
  • Surfactants and Colloidal Systems
  • Hemostasis and retained surgical items
  • Uterine Myomas and Treatments

University of Bonn
2013-2022

Assiut University
2013-2020

10.1016/j.ejpb.2014.03.009 article EN European Journal of Pharmaceutics and Biopharmaceutics 2014-03-22

10.1016/j.ejpb.2017.06.030 article EN European Journal of Pharmaceutics and Biopharmaceutics 2017-07-08

10.1016/j.ijpharm.2013.07.077 article EN International Journal of Pharmaceutics 2013-08-16

Inflammatory bowel disease (IBD) is a chronic inflammatory of the gastrointestinal tract with increasing incidence worldwide. Although deeper understanding underlying mechanisms IBD has led to new therapeutic approaches, treatment options are still limited. Severe adverse events in conventional drug therapy and poor targeting main cause early failure. Nanoparticle-based approaches can selectively deliver drugs site inflammation reduce risk side effects by decreasing systemic availability....

10.3390/pharmaceutics14020352 article EN cc-by Pharmaceutics 2022-02-02

Guillain-Barré Syndrome (GBS) is an autoimmune disease of demyelination and inflammation peripheral nerves. Current treatments are limited to plasma exchange intravenous immunoglobulins. Cargo-free nanoparticles (NPs) have been evaluated here for their therapeutic benefit on the course experimental neuritis (EAN), mimicking human GBS. NPs prepared from poly-lactic co-glycolic acid (PLGA) with variable size surface charge (i.e., 500 nm vs. 130 nm, polyvinyl alcohol (PVA) sodium cholate), were...

10.3390/pharmaceutics14112410 article EN cc-by Pharmaceutics 2022-11-08
Coming Soon ...